Table 1.

Patient demographics and clinical characteristics

Characteristics
Sex (male/female)8/4
Age (years)49 (31–66)
Weight (kg)85 (63–109)
Height (cm)174 (154–193)
ECOG/Zubrod performance status, n (%)
 0, n (%)3 (25%)
 1, n (%)7 (58%)
 2, n (%)2 (17%)
Extent of resection
 GTR, n (%)8 (67%)
 STR, n (%)4 (33%)
 Unknown, n (%)0 (0%)
Prior bevacizumab, n (%)0 (0%)
Timing of ribociclib, n (%)
 First progression8 (67%)
 Second progression1 (8%)
 Third progression2 (17%)
 Fourth progression1 (8%)
Alanine aminotransferase (IU/L)17.5 (10–39)
Aspartate aminotransferase (IU/L)16 (10–115)
Total bilirubin (mg/dL)0.6 (0.3–1)
Serum albumin4.2 (3.6–4.8)
Serum creatinine0.93 (0.67–3.8)